Quality of life in cutaneous lymphoma patients: patient-reported outcomes

Quality of life in cutaneous lymphoma patients: patient-reported outcomes

VJHemOnc

1 year
110 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Pablo Ortiz, MD, PhD, of the University Hospital 12 of October, Madrid, Spain, speaks at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland, on the quality of life of patients with cutaneous T-cell lymphoma. Prof. Ortiz expresses his concerns about clinical outcomes and patient expectations as a doctor, and highlights the need to gather more information on patient-reported outcomes to support the decision-making process of doctors.
Up Next Autoplay
Observations from PROVe Study #EORTC2019
Observations from PROVe Study #EORTC2019
Category: Non-Hodgkin Lymphoma
27 Views
Cancer-News 1 month
PROVe Study: How Long Are Patients On Therapy? #EORTC2019
PROVe Study: How Long Are Patients On Therapy? #EORTC2019
Category: Non-Hodgkin Lymphoma
14 Views
Cancer-News 1 month
PROVe study: Treatment of MF-CTCL Patients #EORTC2019
PROVe study: Treatment of MF-CTCL Patients #EORTC2019
Category: Non-Hodgkin Lymphoma
20 Views
Cancer-News 1 month
Verastem Oncology Receives Orphan Drug Designation from FDA for COPIKTRA for the Treatment of T-Cell Lymphoma
Verastem Oncology Receives Orphan Drug Designation from FDA for COPIKTRA for the Treatment of T-Cell Lymphoma
Category: Non-Hodgkin Lymphoma
14 Views
Cancer-News 1 month
CLL and Non-Hodgkin Lymphoma, What new drugs are on the horizon and why are they exciting
CLL and Non-Hodgkin Lymphoma, What new drugs are on the horizon and why are they exciting
Category: Non-Hodgkin Lymphoma
231 Views
cancergrace 4 months
CLL and Non-Hodgkin Lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib
CLL and Non-Hodgkin Lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib
Category: Non-Hodgkin Lymphoma
125 Views
cancergrace 4 months
Chronic Lymphocytic Leukemia,  Non-Hodgkin Lymphoma, Should all HL patients be treated the same
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Should all HL patients be treated the same
Category: Non-Hodgkin Lymphoma
115 Views
cancergrace 4 months
The Clinical Study Investigating Mosunetuzumab
The Clinical Study Investigating Mosunetuzumab
Category: Non-Hodgkin Lymphoma
111 Views
obr 10 months
Results Of The AUGMENT Study In Relapsed/Refractory Indolent NHL
Results Of The AUGMENT Study In Relapsed/Refractory Indolent NHL
Category: Non-Hodgkin Lymphoma
47 Views
obr 10 months
Non-hodgkin lymphoma advances in 2018
Non-hodgkin lymphoma advances in 2018
Category: Non-Hodgkin Lymphoma
179 Views
VJHemOnc 1 year